Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma

Background: The expression of INMT (indolethylamine N-methyltransferase) has been reported to be downregulated in non-small-cell lung cancer (NSCLC). However, the role of INMT in NSCLC remains elusive. We aim to investigate the underlying mechanisms and clinical value of INMT in NSCLC, especially in...

Full description

Bibliographic Details
Main Authors: Xincheng Zhou, Bing Zou, Jian Wang, Lihong Wu, Qiang Tan, Chunyu Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Genetics
Subjects:
INMT
lung adenocarcinoma
prognosis
immunotherapy
cell cycle
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.946848/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.946848/full

Similar Items